Fig 1. Kaplan–Meier curves for composite adverse events (mortality or major vascular events).

The patients with albuminuria (urine albumin-to-creatinine ratio ≥ 30 mg/g) had a significantly higher rate of composite adverse events than the patients without albuminuria (P < 0.001 by log-rank test).